Literature DB >> 1920483

Prospective study of serum cholesterol levels and large-bowel cancer.

A M Nomura1, G N Stemmermann, P H Chyou.   

Abstract

Based on previous reports, it is uncertain whether serum cholesterol levels are inversely related to colon cancer risk. In this study, serum cholesterol levels were measured in 7926 Japanese-American men who were followed for over 20 years. Two hundred thirty-one incident cases of colon cancer and 97 cases of rectal cancer were identified. An increase in serum cholesterol levels was associated with a decrease in risk for colon cancer (P value for trend = .01) but not for rectal cancer. This association appeared stronger as the site of cancer moved from the sigmoid colon to the cecum. The data were further analyzed by interval from examination to diagnosis. The inverse association was present for colon cancer cases diagnosed within 10 years of examination (P value for trend less than .01), especially for cecum-ascending colon cancer cases (P less than .01). A similar inverse pattern was found for cecum-ascending colon cancer cases diagnosed after 10 years, but the association was not statistically significant. The results suggest that the preclinical effects of undiagnosed colon cancer contributed to the inverse association, but these effects do not entirely explain why the relationship with hypocholesterolemia was stronger in men who were subsequently diagnosed with right-sided colon cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920483     DOI: 10.1093/jnci/83.19.1403

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Effect of cholesterol levels on villous histology in colonic adenomas.

Authors:  J Houghton; G G Lardieri; N P Zauber; K H Kim; G Cable
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer.

Authors:  Ikuko Kato; Susan Land; Adhip P Majumdar; Jill Barnholtz-Sloan; Richard K Severson
Journal:  Cancer Epidemiol       Date:  2010-03-21       Impact factor: 2.984

3.  Metabolic abnormalities and risk for colorectal cancer in the physicians' health study.

Authors:  Til Stürmer; Julie E Buring; I-Min Lee; J Michael Gaziano; Robert J Glynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-12       Impact factor: 4.254

4.  Serum lipids and left-sided adenomas of the large bowel: an extended study of self-defense officials in Japan.

Authors:  S Kono; K Imanishi; K Shinchi; F Yanai
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

5.  Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.

Authors:  Konstantinos K Tsilidis; Frederick L Brancati; Michael N Pollak; Nader Rifai; Sandra L Clipp; Judith Hoffman-Bolton; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-09-23       Impact factor: 2.506

6.  Lipid profile in leukemia and Hodgkin's disease.

Authors:  P P Naik; M S Ghadge; A S Raste
Journal:  Indian J Clin Biochem       Date:  2006-09

7.  Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis.

Authors:  Chang Gong Li; Mike Gruidl; Steven Eschrich; Susan McCarthy; Hong-Gang Wang; Mark G Alexandrow; Timothy J Yeatman
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

8.  Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies.

Authors:  Chen Zhang; Yunjiu Cheng; Dongling Luo; Jinghua Wang; Jianhua Liu; Yujun Luo; Weijie Zhou; Zewei Zhuo; Kehang Guo; Ruijie Zeng; Jun Yang; Weihong Sha; Hao Chen
Journal:  EClinicalMedicine       Date:  2021-03-18

9.  Site-specific risk factors for colorectal cancer in a Korean population.

Authors:  Aesun Shin; Jungnam Joo; Jeongin Bak; Hye-Ryung Yang; Jeongseon Kim; Sohee Park; Byung-Ho Nam
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  Hypolipidemia: a word of caution.

Authors:  Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.